Skip to search formSkip to main contentSkip to account menu

Indium-111-CYT-356

Known as: (III)In-CYT-356 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Capromab Pendetide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1996
1996
Radiation absorbed dose from indium-111-CYT-356.
UNLABELLED Indium-CYT-356 is an agent developed by CYTOGEN Inc. (CYT) (Princeton, NJ) for the use in staging patients with… 
Highly Cited
1996
Highly Cited
1996
Treatment of hormone-refractory prostate cancer with 90Y-CYT-356 monoclonal antibody.
A Phase I dose-escalation study using 90Y-CYT-356 monoclonal antibody was performed in 12 patients with hormone-refractory… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)